Product Information
ABACAVIR 300 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.6012 per EA under NDC 00904687406. Its NADAC has been published 336 times since Jan 22, 2020.
Strength
300 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904687406
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ABACAVIR SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA077844On Market Since
12/17/2012
Pharmacological Classes
Price Statistics
The NADAC for ABACAVIR 300 MG TABLET has been published 336 times since Jan 22, 2020, and over the history we have for it it has declined 38.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6012 per EA |
|---|---|
| All-time high | $0.9760 (Feb 12, 2020) |
| All-time low | $0.4392 (Dec 22, 2021) |
| 52-week high | $0.6820 |
| 52-week low | $0.6012 |
| Median price | $0.6502 |
| Average price | $0.6643 |
| Largest weekly change | +59.4% (Feb 23, 2022) |
| Weeks tracked | 336 |
| Tracking since | Jan 22, 2020 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ABACAVIR 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ABACAVIR 300 MG TABLET, manufactured by Major Pharmaceuticals, is $0.6012 per EA (NDC 00904687406), effective Jun 24, 2026.
How has the price of ABACAVIR 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for ABACAVIR 300 MG TABLET has declined 38.4%. It has been tracked across 336 weekly CMS publications since Jan 22, 2020.
What are the highest and lowest recorded NADAC prices for ABACAVIR 300 MG TABLET?
Since Jan 22, 2020, the NADAC for ABACAVIR 300 MG TABLET has ranged from a low of $0.4392 (Dec 22, 2021) to a high of $0.9760 (Feb 12, 2020), with a median of $0.6502 per EA.
Are there cheaper alternatives to ABACAVIR 300 MG TABLET?
6 NADAC-published products share the same active ingredient, strength, and dosage form as ABACAVIR 300 MG TABLET, but none are currently priced below it.
Who manufactures ABACAVIR 300 MG TABLET?
ABACAVIR 300 MG TABLET (NDC 00904687406) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.
Related Drugs
Same classification